Spinal Cord Infarcts: Risk Factors, Management, and Prognosis

Research output: Contribution to journalReview article

5 Scopus citations

Abstract

There are no standard guidelines for treatment of spinal cord ischemia due to how rare it is and the diverse etiology and presentations involved. In addition, to date, there have been no large clinical trials examining ideal pharmacologic treatment options for spinal cord infarct. In our practice, we rely on hemodynamic augmentation initiated as soon as possible. Otherwise, treatment is usually geared towards the etiology of spinal cord ischemia. For instance, spinal cord ischemia occurring after aortic aneurysmal repair may improve with CSF drainage through a lumbar catheter in the periprocedural setting. Vertebral artery dissection should be treated with antithrombotics. If no clear etiology is found and there is evidence of atherosclerosis in other vascular beds, then management is focused on risk factor modification with blood pressure and glucose control, statins, and antithrombotics.

Original languageEnglish (US)
Article number28
JournalCurrent Treatment Options in Neurology
Volume19
Issue number8
DOIs
StatePublished - Aug 1 2017

Keywords

  • Spinal cord infarct
  • Vascular myelopathy

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Spinal Cord Infarcts: Risk Factors, Management, and Prognosis'. Together they form a unique fingerprint.

  • Cite this